A ‘secret’ patch shows the future of treating the most common food allergy, and two biotechs are competing to own the $3 billion market

Dec 9, 2018

A ‘secret’ patch shows the future of treating the most common food allergy, and two biotechs are competing to own the $3 billion market

Posted by Genevieve Klien in categories: biotech/medical, health

Kids with peanut allergies haven’t had many options, but that first-of-their-kind treatments could change that as soon as 2019.

Comments are closed.

GETAS THREAT LEVEL: ELEVATED
FACEBOOK: 13,856 MEMBERS
LINKEDIN: 2,066 MEMBERS
TWITTER FEED: 31,711 MEMBERS
GETTR FEED: 39,482 MEMBERS

LIFEBOAT NEWS: 3,402 SUBSCRIBERS
GETAS ALERTS: 573 SUBSCRIBERS
BLOG: 119,864 POSTS
DONORS: 5,968

BOARDS: 2,934 MEMBERS
REPORTS: 74
PROGRAMS: 25
FORUMS: 24
QUOTES: 136

FIGHT AIDS: 3 MEMBERS
FOLDING@HOME: 15 MEMBERS
ROSETTA@HOME: 44 MEMBERS

© 2002–2024 Lifeboat Foundation